MedPath

Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine Learning

Conditions
Oral Squamous Cell Carcinoma
Interventions
Procedure: Surgery
Registration Number
NCT04543266
Lead Sponsor
The University of Hong Kong
Brief Summary

Application Management Team:

PI - Siu Wai Choi; email - htswchoi@hku.hk Delegates - Chui Shan Chu; email: sunshine.c@connect.hku.hk FollowUpUsers - Chui Shan Chu; email:sunshine.c@connect.hku.hk

Detailed Description

Eligibility Criteria:

- patients were diagnosed with a baseline disease of oral squamous carcinoma.

Exclusion Criteria:

- N/A

Sample size:

- \~500 subjects

Source of Data:

- The data, such as age and medical records, would be obtained from Hospital Authority Clinical Management System (HACMS)

Statistical analysis:

- machine learning will be applied into analysis plan

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
500
Inclusion Criteria
  • patients with oral squamous carcinoma
  • received surgery from 1st October 2000 to 1st October 2019
Read More
Exclusion Criteria

N/A

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients without Progressive DiseaseSurgeryPatients without metastasis and/or recurrent OSCC were considered as a group of subjects without progressive disease
Patients with Progressive DiseaseSurgeryPatients with metastasis and/or recurrent OSCC were considered as a group of subjects with progressive disease
Primary Outcome Measures
NameTimeMethod
The primary outcomes of the study are metastasis and recurrent diseaseBaseline of OSCC

These outcomes will be entered as the dependent variables into the machine learning model

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The University of Hong Kong

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath